Doctor Atsushi Tada
Mayo Clinic, Rochester (United States of America)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Primary inflammatory disease in heart failure with preserved ejection fraction
Event: ESC Congress 2024
Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)
Session: Cardiac amyloidosis, sarcoidosis, and inflammation
Dapagliflozin enhances arterial and venous compliance during exercise in heart failure with preserved ejection fraction
Event: ESC Congress 2024
Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)
Session: Diagnosis and prognosis of HFpEF
Prognostic value of liver fibrotic markers in patients with heart failure
Event: ESC Congress 2023
Topic: Biomarkers
Session: Emerging evidence for biomarkers in heart failure
Validation of the HFA-PEFF and the H2FPEF scores for the diagnosis of heart failure with preserved ejection fraction in Japanese patients:a report from the Japanese multicentre registry
Event: ESC Congress 2021 - The Digital Experience
Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)
Session: Chronic heart failure e-posters
